Call Options

22 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$772.14 - $960.02 $40.9 Million - $50.9 Million
-53,000 Reduced 47.62%
58,300 $51.7 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $77.9 Million - $97.7 Million
107,500 Added 2828.95%
111,300 $101 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $23.5 Million - $31.4 Million
-39,600 Reduced 91.24%
3,800 $2.96 Million
Q4 2023

Feb 15, 2024

BUY
$525.19 - $619.13 $22.8 Million - $26.9 Million
43,400 New
43,400 $25.3 Million
Q1 2023

May 04, 2023

SELL
$310.63 - $364.82 $26.9 Million - $31.6 Million
-86,600 Reduced 62.57%
51,800 $17.8 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $44.5 Million - $51.9 Million
138,400 New
138,400 $50.6 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1.66 Million - $2.06 Million
7,400 Added 284.62%
10,000 $2.76 Million
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $4.68 Million - $6.06 Million
-28,500 Reduced 91.64%
2,600 $486,000
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $3.55 Million - $4.7 Million
27,200 Added 697.44%
31,100 $5.25 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $4.61 Million - $5.33 Million
-31,500 Reduced 88.98%
3,900 $577,000
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $26.2 Million - $31.6 Million
-192,200 Reduced 84.45%
35,400 $5.81 Million
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $16 Million - $19.7 Million
134,000 Added 143.16%
227,600 $31.6 Million
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $4.41 Million - $5.46 Million
-41,200 Reduced 30.56%
93,600 $12.3 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $5.97 Million - $6.49 Million
55,900 Added 70.85%
134,800 $15.1 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $76.9 Million - $89.8 Million
-694,200 Reduced 89.79%
78,900 $8.74 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $81.7 Million - $96.2 Million
734,200 Added 1887.4%
773,100 $100 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $13.4 Million - $15.1 Million
-127,000 Reduced 76.55%
38,900 $4.5 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $6.1 Million - $7.63 Million
-71,100 Reduced 30.0%
165,900 $17.8 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $408,780 - $469,152
-5,400 Reduced 2.23%
237,000 $20.2 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $9.77 Million - $11.5 Million
131,700 Added 118.97%
242,400 $18.8 Million
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $3.87 Million - $4.15 Million
-47,200 Reduced 29.89%
110,700 $9.35 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $12.2 Million - $13.5 Million
157,900
157,900 $13.5 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.